300313 *ST天山生物
按盤價 
9.600 +0.080 (+0.840%)
9.600 +0.080 (+0.840%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -76.429 | -225.890 | -30.069 | -33.810 | -21.075 |
| 總資產報酬率 ROA (%) | -4.451 | -23.410 | -6.793 | -8.700 | -4.180 |
| 投入資產回報率 ROIC (%) | -7.748 | -55.083 | -13.037 | -14.583 | -8.625 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.947 | -5.230 | 16.986 | 14.166 | 7.089 |
| 營業利潤率 (%) | -12.960 | -44.576 | -13.572 | -36.988 | -26.047 |
| 息稅前利潤/營業總收入 (%) | -0.750 | -38.280 | -6.278 | -21.879 | -13.434 |
| 淨利潤/營業總收入 (%) | -18.749 | -48.748 | -16.061 | -41.952 | -28.149 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 165.000 | 73.168 | 80.289 | 73.521 | 117.534 |
| 價值變動淨收益/利潤總額(%) | -28.772 | -5.374 | -15.069 | 26.411 | -2.921 |
| 營業外收支淨額/利潤總額(%) | 3.175 | 3.255 | 3.340 | 7.324 | 1.479 | 償債能力分析 |
| 流動比率 (X) | 1.036 | 0.321 | 0.484 | 0.521 | 0.633 |
| 速動比率 (X) | 0.295 | 0.226 | 0.168 | 0.281 | 0.527 |
| 資產負債率 (%) | 83.933 | 97.711 | 77.162 | 71.714 | 71.353 |
| 帶息債務/全部投入資本 (%) | 32.910 | 85.081 | 50.434 | 47.535 | 53.899 |
| 股東權益/帶息債務 (%) | 48.531 | -5.126 | 80.674 | 95.850 | 76.713 |
| 股東權益/負債合計 (%) | 14.765 | -1.558 | 25.559 | 35.290 | 36.558 |
| 利息保障倍數 (X) | -0.059 | -4.910 | -0.809 | -1.213 | -1.033 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.070 | 34.041 | 25.984 | 82.715 | 61.330 |
| 存貨周轉天數 (天) | 250.337 | 113.040 | 199.698 | 228.050 | 133.930 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
